Caspase-1 inhibition ameliorates pulmonary tissue damage as well as pulmonary edema in LPS-induced ALI, implying that caspase-1 could be a therapeutic target in the treatment of patients with ALI [54]. Here, CASP1 is linked to acute respiratory distress syndrome.